FDA Has Shelved Its Fast-Track Drug Voucher Program, Reuters Reports
The Food and Drug Administration has quietly shelved the Commissioner's National Priority Voucher program, which promised drug reviews in one to two months for products tied to national priorities, Reuters reports, citing six sources and internal documents. The program was launched in June 2025 under former Commissioner Marty Makary, who left in May; 22 drugs received vouchers and 12 have been approved, but no new vouchers have been issued since he left and the agency has had no commissioner since. Critics had raised concerns about political influence in how drugs were chosen. An HHS spokesperson, Emily Hilliard, told Reuters the pilot is ongoing and the FDA is reviewing feedback from a June public hearing.
Sources